Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Medication Guide

Ivermectin, Praziquantel

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Non-Rx Paste Multiple FDA labelers Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Jun 22, 2026, 10:41 a.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Jun 22, 2026, 10:41 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
No safety reports linked
No refresh timestamp yet

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
Image coming soon
Ivermectin, Praziquantel

Ivermectin, Praziquantel

Drug type: Generic ingredient • Branded profile • FDA branded products available

Both Paste Non-Rx 100% reference complete

Species: Both

Manufacturer: Multiple FDA labelers

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Ivermectin, Praziquantel

For treatment and control of the following parasites in horses: tapeworms-- Anoplocephala perfoliata ; large strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S. edentates (also tissue stages), S. equinus, Triodontophorus species including T. brevicauda and T. serratus, and Craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds)-- Coronocyclus species including C. coronatus, C. labiatus, and C. labratus, Cyathostomum species including C. catinatum and C. pateratum, Cylicocyclus species including C. insigne, C. leptostomum, C. nassatus, and C. brevicapsulatus, Cylicodontophorus species, Cylicostephanus species including C. calicatus, C. goldi, C. longibursatus, and C. minutus, and Petrovinema poculatum ; small strongyles-fourth-stage larvae; pinworms (adults and fourth stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; hairworms (adults)-- Trichostrongylus axei ; large-mouth stomach worms (adults)-- Habronema muscae ; bots (oral and gastric stages)-- Gasterophilus species including G. intestinalis and G. nasalis ; lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; intestinal threadworms (adults)-- Strongyloides westeri ; summer sores caused by Habronema and Draschia species cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For treatment and control of the following parasites in horses: Tapeworms-- Anoplocephala perfoliata ; Large Strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S.edentatus (also tissue stages), S. equinus, Triodontophorus spp.; Small Strongyles (adults, including those resistant to some benzimidazole class compounds)-- Cyathostomum species, Cylicocyclus species, Cylicostephanus species, Cylicodontophorus species; Small Strongyles--fourth-stage larvae; Pinworms (adults and fourth-stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; Hairworms (adults)-- Trichostrongylus axei ; Large-mouth Stomach Worms (adults)-- Habronema muscae ; Bots (oral and gastric stages)-- Gasterophilus species; Lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; Intestinal Threadworms (adults)-- Strongyloides westeri ; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata ; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edentatus (also tissue stages), S. equinus, Triodontophorus spp. including T. brevicauda and T. serratus, and Craterostomum acuticaudatum ; Small Strongyles (adults, including those resistant to some benzimidazole class compounds) - Coronocyclus spp Species commonly shown: Both, Horse, Foals 2 Months And Older, Not For Food, Horse.

Generic name
Ivermectin, Praziquantel
Brand names
ZIMECTERIN® Gold Paste, Equimax®, Duocare™, Equimax
Manufacturer
Multiple FDA labelers
Species
Both, Horse
Dosage forms
Paste
Prescription
Non-prescription
Completeness
100%
Validation
Complete
Brand names
ZIMECTERIN® Gold Paste Equimax® Duocare™ Equimax Prazimectin ZIMECTERIN GOLD
Dosage forms
Paste

Indications / Uses

For treatment and control of the following parasites in horses: tapeworms-- Anoplocephala perfoliata ; large strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S. edentates (also tissue stages), S. equinus , Triodontophorus species including T. brevicauda and T. serratus , and Craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds)-- Coronocyclus species including C. coronatus , C. labiatus , and C. labratus , Cyathostomum species including C. catinatum and C. pateratum , Cylicocyclus species including C. insigne , C. leptostomum , C. nassatus , and C. brevicapsulatus , Cylicodontophorus species, Cylicostephanus species including C. calicatus , C. goldi , C. longibursatus , and C. minutus , and Petrovinema poculatum ; small strongyles-fourth-stage larvae; pinworms (adults and fourth stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; hairworms (adults)-- Trichostrongylus axei ; large-mouth stomach worms (adults)-- Habronema muscae ; bots (oral and gastric stages)-- Gasterophilus species including G. intestinalis and G. nasalis ; lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; intestinal threadworms (adults)-- Strongyloides westeri ; summer sores caused by Habronema and Draschia species cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For treatment and control of the following parasites in horses: Tapeworms-- Anoplocephala perfoliata ; Large Strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S.edentatus (also tissue stages), S. equinus , Triodontophorus spp.; Small Strongyles (adults, including those resistant to some benzimidazole class compounds)-- Cyathostomum species, Cylicocyclus species, Cylicostephanus species, Cylicodontophorus species; Small Strongyles--fourth-stage larvae; Pinworms (adults and fourth-stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; Hairworms (adults)-- Trichostrongylus axei ; Large-mouth Stomach Worms (adults)-- Habronema muscae ; Bots (oral and gastric stages)-- Gasterophilus species; Lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; Intestinal Threadworms (adults)-- Strongyloides westeri ; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata ; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edentatus (also tissue stages), S. equinus , Triodontophorus spp. including T. brevicauda and T. serratus , and Craterostomum acuticaudatum ; Small Strongyles (adults, including those resistant to some benzimidazole class compounds) - Coronocyclus spp

Warnings / Contraindications

For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption.

  • For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption.

FAQ

Both, Horse, Foals 2 Months And Older, Not For Food, Horse

No. Roxee does not currently show this as prescription-only.

Paste

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata ; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edenta...

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • For oral use only
  • Do not use in horses intended for human consumption
  • This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result
  • For oral use in horses only
  • This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence
Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Limited Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Ivermectin, Praziquantel; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA adverse-event data
Safety signal coverage No signal rollup

No source-backed adverse-reaction rollup is linked yet. That is a data gap, not proof that no reactions occur.

Source: openFDA adverse-event data
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA adverse-event data
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Reaction signal map Limited data

No source-backed adverse-reaction rollup is linked yet for this medication. Use the owner watch list, official documents, and veterinary guidance.

What your vet may verify

Fit for this patient Vet check

Verify whether Ivermectin, Praziquantel fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

For oral use only, Do not use in horses intended for human consumption, This product should not be used in other animal species as severe adverse reactions, including fatal, For oral use in horses only, This product should not be used in other animal species as severe adverse reactions, including fatal

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Roxee has limited reaction-signal depth for Ivermectin, Praziquantel right now. Use veterinary instructions, official documents, and direct clinic guidance for decisions.
Vet source depth
  1. openFDA adverse-event data · openfda · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. FDA application profile · official_label · quick facts
  5. Medication usage source · fda_animal_drugs · quick facts
  6. FOI · document · documents
  7. SPL · document · documents
  8. FOI · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 22, 2026, 10:06 AM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • For oral use only
  • Do not use in horses intended for human consumption
  • This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result
  • For oral use in horses only
  • This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Horse
Indication / use
For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata ; Large Strongyles (adults) - Strongylus vulgaris (also…
Form / route / dose
Form: Paste
Route: Oral
Confirm product label and patient-specific plan.
Warnings
  • High: For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal…
Adverse-event caveat
No stored openFDA case explorer rows are linked yet.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA labelers
Form: Paste
Identifiers:
NADA: 141214 NADA: 141215 NADA: 141421 NDC Package: 0010-6001-03 NDC Package: 0010-6001-04 NDC Package: 61133-7000-1 NDC Package: 86213-773-01 NDC Product: 0010 NDC Product: 61133 NDC Product: 86213
Source metadata:

Warnings / Contraindications

For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption.

  • High: For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption.
Source metadata:

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Duocare™ SPL · SPL ZIMECTERIN® Gold Paste SPL · SPL Equimax® SPL · SPL

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

6

FOI

7

Duocare™

SPL · SPL

Open original
FDA Structured Product Label

Duocare™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA Inc.
NADA
141-421
Status
OTC
Form
Paste
Route
Oral
Composition / specifications
Each milligram of Duocare™ paste contains 0.0187 mg (1.87%) ivermectin and 0.2338 mg (23.38%) praziquantel. Each syringe contains 113.75 mg of ivermectin and 1421.5 mg of praziquantel.

Horses

Indication
For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edentatus (also tissue stages), S. equinus, Triodontophorus spp. including T. brevicauda and T. serratus, and Craterostomum acuticaudatum; Small Strongyles (adults, including those resistant to some benzimidazole class compounds) - Coronocyclus spp. including C. coronatus, C. labiatus and C. labratus; Cyathostomum spp. including C. catinatum and C. pateratum; Cylicocyclus spp. including C. insigne, C. leptostomum, C. nassatus and C. brevicapsulatus; Cylicodontophorus spp. Cylicostephanus spp. including C. calicatus, C. goldi, C. longibursatus and C. minutus, and Petrovinema poculatum; Small Strongyles - Fourth-stage larvae; Pinworms (adults and fourth-stage larvae)- Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae) - Parascaris equorum; Hairworms (adults) - Trichostrongylus axei; Large-mouth Stomach Worms (adults) - Habronema muscae; Bots (oral and gastric stages) - Gasterophilus spp. including G. intestinalis and G. nasalis; Lungworms (adults and fourth-stage larvae) - Dictyocaulus arnfieldi; Intestinal Threadworms (adults) - Strongyloides westeri; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca sp.
Dosage
200 mcg/kg ivermectin (91 mcg/lb) and 2.5 mg/kg praziquantel (1.14 mg/lb).
Limitations
Do not use in horses intended for human consumption.

ZIMECTERIN® Gold Paste

SPL · SPL

Open original
FDA Structured Product Label

ZIMECTERIN® Gold Paste

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Boehringer Ingelheim Animal Health USA, Inc.
NADA
141-214
Status
OTC
Form
Paste
Route
Oral
Species
Horse
Composition / specifications
Each milligram of paste contains 0.0155 milligram (1.55 percent) ivermectin and 0.0775 milligram (7.75 percent) praziquantel.

Horses

Indication
For treatment and control of the following parasites in horses: tapeworms--Anoplocephala perfoliata; large strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S. edentates (also tissue stages), S. equinus, Triodontophorus species including T. brevicauda and T. serratus, and Craterostomum acuticaudatum; small strongyles (adults, including those resistant to some benzimidazole class compounds)--Coronocyclus species including C. coronatus, C. labiatus, and C. labratus, Cyathostomum species including C. catinatum and C. pateratum, Cylicocyclus species including C. insigne, C. leptostomum, C. nassatus, and C. brevicapsulatus, Cylicodontophorus species, Cylicostephanus species including C. calicatus, C. goldi, C. longibursatus, and C. minutus, and Petrovinema poculatum; small strongyles-fourth-stage larvae; pinworms (adults and fourth stage larvae)--Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae)--Parascaris equorum; hairworms (adults)--Trichostrongylus axei; large-mouth stomach worms (adults)--Habronema muscae; bots (oral and gastric stages)--Gasterophilus species including G. intestinalis and G. nasalis; lungworms (adults and fourth-stage larvae)--Dictyocaulus arnfieldi; intestinal threadworms (adults)--Strongyloides westeri; summer sores caused by Habronema and Draschia species cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species.
Dosage

200 microgram per kilogram ivermectin (91 microgram per pound) and 1 milligram per kilogram praziquantel (454 micrograms per pound) body weight.

Limitations
For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.

Equimax®

SPL · SPL

Open original
FDA Structured Product Label

Equimax®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Virbac AH, Inc.
NADA
141-215
Status
OTC
Form
Paste
Route
Oral
Species
Horse
Composition / specifications
Each milligram of paste contains 0.0187 mg (1.87 percent) ivermectin and 0.1403 mg (14.03 percent) praziquantel.

Horses

Indication
For treatment and control of the following parasites in horses: Tapeworms--Anoplocephala perfoliata; Large Strongyles (adults)--Strongylus vulgaris (also early forms in blood vessels), S.edentatus (also tissue stages), S. equinus, Triodontophorus spp.; Small Strongyles (adults, including those resistant to some benzimidazole class compounds)--Cyathostomum species, Cylicocyclus species, Cylicostephanus species, Cylicodontophorus species; Small Strongyles--fourth-stage larvae; Pinworms (adults and fourth-stage larvae)--Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae)--Parascaris equorum; Hairworms (adults)--Trichostrongylus axei; Large-mouth Stomach Worms (adults)--Habronema muscae; Bots (oral and gastric stages)--Gasterophilus species; Lungworms (adults and fourth-stage larvae)--Dictyocaulus arnfieldi; Intestinal Threadworms (adults)--Strongyloides westeri; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species.
Dosage
200 microgram per kilogram ivermectin (91 microgram per pound) and 1.5 milligram per kilogram praziquantel (.68 milligram per pound) body weight.
Limitations
For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result

ZIMECTERIN GOLD SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for ZIMECTERIN GOLD. Use the source link for the full official labeling record.

Prazimectin SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Prazimectin. Use the source link for the full official labeling record.

Equimax SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Equimax. Use the source link for the full official labeling record.

UCM408781.pdf

FOI · FOI

Open original

ucm118012.pdf

FOI · FOI

Open original

ucm118011.pdf

FOI · FOI

Open original

ucm118009.pdf

FOI · FOI

Open original

ucm118017.pdf

FOI · FOI

Open original

ucm118016.pdf

FOI · FOI

Open original

ucm118014.pdf

FOI · FOI

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Jun 22, 2026, 10:41 AM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Jun 22, 2026, 10:40 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Jun 22, 2026, 10:41 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Equimax Prazimectin ZIMECTERIN GOLD
Manufacturer mapping: Multiple FDA labelers
Catalog species: Both • FDA-labeled species: Horse
Rx/OTC: OTC
Form/route: Paste • Oral
Applications: NADA 141-421 • NADA 141-214 • NADA 141-215
NDC: Packages 0010-6001-03 0010-6001-04 61133-7000-1 86213-773-01 • Products 0010 61133 86213
Documents: 7 (FOI: 7) • SPL: 3 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 0 • Cat 0
Case summaries: 0
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption. (Contraindication, High)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NADA: 141214 NADA: 141215 NADA: 141421 NDC Package: 0010-6001-03 NDC Package: 0010-6001-04 NDC Package: 61133-7000-1 NDC Package: 86213-773-01 NDC Product: 0010 NDC Product: 61133 NDC Product: 86213
Package NDC Product NDC Form / Route Status
0010-6001-03 0010 -
0010-6001-04 0010 -
61133-7000-1 61133 -
86213-773-01 86213 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • ZIMECTERIN GOLD SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Prazimectin SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • Equimax SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.
  • UCM408781.pdf • FOI summary • Official • May 15, 2024
    FDA FOI summary for application 141421
  • ucm118009.pdf • FOI summary • Official • July 26, 2021
    FDA FOI summary for application 141214
  • ucm118011.pdf • FOI summary • Official • July 26, 2021
    FDA FOI summary for application 141214
  • ucm118012.pdf • FOI summary • Official • July 26, 2021
    FDA FOI summary for application 141214
  • ucm118014.pdf • FOI summary • Official • Dec. 18, 2017
    FDA FOI summary for application 141215
  • ucm118016.pdf • FOI summary • Official • Dec. 18, 2017
    FDA FOI summary for application 141215
  • ucm118017.pdf • FOI summary • Official • Dec. 18, 2017
    FDA FOI summary for application 141215

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 130 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, in… (Official, 2026-04-22)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-22)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-22)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-21)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-20)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-13)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-12)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-12)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-11)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-11)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-10)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-09)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-08)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-07)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-06)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-05)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-04)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-03)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-02)
  • indications: For the treatment and control of the following parasites in horses over 5 months of age: TapewormsAnoplocephala perfoliata; Large Strongyles (adults) - Strongy… (Official, 2026-06-01)
Recent Revisions
  • contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Duocare™
OTC
Ivermectin Praziquantel
Paste • Oral
Label highlights
Official documents
Boehringer Ingelheim Animal Health USA Inc. NADA 141-421 W May 15, 2024
ZIMECTERIN® Gold Paste
OTC
Ivermectin Praziquantel
Paste • Oral
Label highlights
Official documents
Boehringer Ingelheim Animal Health USA, Inc. NADA 141-214 Approved Jul 26, 2021
Equimax®
OTC
Ivermectin Praziquantel
Paste • Oral
Label highlights
Official documents
Virbac AH, Inc. NADA 141-215 Approved Dec 18, 2017

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
Each milligram of Duocare™ paste contains 0.0187 mg (1.87%) ivermectin and 0.2338 mg (23.38%) praziquantel. Each syringe contains 113.75 mg of ivermectin and 1421.5 mg of praziquantel.
Horses
Indication
For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edentatus (also tissue stages), S. equinus, Triodontophorus spp. including T. brevicauda and T. serratus, and Craterostomum acuticaudatum; Small Strongyles (adults, including those resistant to some benzimidazole class compounds) - Coronocyclus spp. including C. coronatus, C. labiatus and C. labratus; Cyathostomum spp. including C. catinatum and C. pateratum; Cylicocyclus spp. including C. insigne, C. leptostomum, C. nassatus and C. brevicapsulatus; Cylicodontophorus spp. Cylicostephanus spp. including C. calicatus, C. goldi, C. longibursatus and C. minutus, and Petrovinema poculatum; Small Strongyles - Fourth-stage larvae; Pinworms (adults and fourth-stage larvae)- Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae) - Parascaris equorum; Hairworms (adults) - Trichostrongylus axei; Large-mouth Stomach Worms (adults) - Habronema muscae; Bots (oral and gastric stages) - Gasterophilus spp. including G. intestinalis and G. nasalis; Lungworms (adults and fourth-stage larvae) - Dictyocaulus arnfieldi; Intestinal Threadworms (adults) - Strongyloides westeri; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca sp.
Dosage
200 mcg/kg ivermectin (91 mcg/lb) and 2.5 mg/kg praziquantel (1.14 mg/lb).
Limitations
Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each milligram of paste contains 0.0155 milligram (1.55 percent) ivermectin and 0.0775 milligram (7.75 percent) praziquantel.
Horses
Indication
For treatment and control of the following parasites in horses: tapeworms--Anoplocephala perfoliata; large strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S. edentates (also tissue stages), S. equinus, Triodontophorus species including T. brevicauda and T. serratus, and Craterostomum acuticaudatum; small strongyles (adults, including those resistant to some benzimidazole class compounds)--Coronocyclus species including C. coronatus, C. labiatus, and C. labratus, Cyathostomum species including C. catinatum and C. pateratum, Cylicocyclus species including C. insigne, C. leptostomum, C. nassatus, and C. brevicapsulatus, Cylicodontophorus species, Cylicostephanus species including C. calicatus, C. goldi, C. longibursatus, and C. minutus, and Petrovinema poculatum; small strongyles-fourth-stage larvae; pinworms (adults and fourth stage larvae)--Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae)--Parascaris equorum; hairworms (adults)--Trichostrongylus axei; large-mouth stomach worms (adults)--Habronema muscae; bots (oral and gastric stages)--Gasterophilus species including G. intestinalis and G. nasalis; lungworms (adults and fourth-stage larvae)--Dictyocaulus arnfieldi; intestinal threadworms (adults)--Strongyloides westeri; summer sores caused by Habronema and Draschia species cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species.
Dosage

200 microgram per kilogram ivermectin (91 microgram per pound) and 1 milligram per kilogram praziquantel (454 micrograms per pound) body weight.

Limitations
For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.

FDA page: Open in Animal Drugs @ FDA

Species: Horse
Composition / specifications
Each milligram of paste contains 0.0187 mg (1.87 percent) ivermectin and 0.1403 mg (14.03 percent) praziquantel.
Horses
Indication
For treatment and control of the following parasites in horses: Tapeworms--Anoplocephala perfoliata; Large Strongyles (adults)--Strongylus vulgaris (also early forms in blood vessels), S.edentatus (also tissue stages), S. equinus, Triodontophorus spp.; Small Strongyles (adults, including those resistant to some benzimidazole class compounds)--Cyathostomum species, Cylicocyclus species, Cylicostephanus species, Cylicodontophorus species; Small Strongyles--fourth-stage larvae; Pinworms (adults and fourth-stage larvae)--Oxyuris equi; Ascarids (adults and third- and fourth-stage larvae)--Parascaris equorum; Hairworms (adults)--Trichostrongylus axei; Large-mouth Stomach Worms (adults)--Habronema muscae; Bots (oral and gastric stages)--Gasterophilus species; Lungworms (adults and fourth-stage larvae)--Dictyocaulus arnfieldi; Intestinal Threadworms (adults)--Strongyloides westeri; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species.
Dosage
200 microgram per kilogram ivermectin (91 microgram per pound) and 1.5 milligram per kilogram praziquantel (.68 milligram per pound) body weight.
Limitations
For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result

FDA page: Open in Animal Drugs @ FDA

Usage

For treatment and control of the following parasites in horses: tapeworms-- Anoplocephala perfoliata ; large strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S. edentates (also tissue stages), S. equinus , Triodontophorus species including T. brevicauda and T. serratus , and Craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds)-- Coronocyclus species including C. coronatus , C. labiatus , and C. labratus , Cyathostomum species including C. catinatum and C. pateratum , Cylicocyclus species including C. insigne , C. leptostomum , C. nassatus , and C. brevicapsulatus , Cylicodontophorus species, Cylicostephanus species including C. calicatus , C. goldi , C. longibursatus , and C. minutus , and Petrovinema poculatum ; small strongyles-fourth-stage larvae; pinworms (adults and fourth stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; hairworms (adults)-- Trichostrongylus axei ; large-mouth stomach worms (adults)-- Habronema muscae ; bots (oral and gastric stages)-- Gasterophilus species including G. intestinalis and G. nasalis ; lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; intestinal threadworms (adults)-- Strongyloides westeri ; summer sores caused by Habronema and Draschia species cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For treatment and control of the following parasites in horses: Tapeworms-- Anoplocephala perfoliata ; Large Strongyles (adults)-- Strongylus vulgaris (also early forms in blood vessels), S.edentatus (also tissue stages), S. equinus , Triodontophorus spp.; Small Strongyles (adults, including those resistant to some benzimidazole class compounds)-- Cyathostomum species, Cylicocyclus species, Cylicostephanus species, Cylicodontophorus species; Small Strongyles--fourth-stage larvae; Pinworms (adults and fourth-stage larvae)-- Oxyuris equi ; Ascarids (adults and third- and fourth-stage larvae)-- Parascaris equorum ; Hairworms (adults)-- Trichostrongylus axei ; Large-mouth Stomach Worms (adults)-- Habronema muscae ; Bots (oral and gastric stages)-- Gasterophilus species; Lungworms (adults and fourth-stage larvae)-- Dictyocaulus arnfieldi ; Intestinal Threadworms (adults)-- Strongyloides westeri ; Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, Onchocerca species. For the treatment and control of the following parasites in horses over 5 months of age: Tapeworms Anoplocephala perfoliata ; Large Strongyles (adults) - Strongylus vulgaris (also early forms in blood vessels), S. edentatus (also tissue stages), S. equinus , Triodontophorus spp. including T. brevicauda and T. serratus , and Craterostomum acuticaudatum ; Small Strongyles (adults, including those resistant to some benzimidazole class compounds) - Coronocyclus spp

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

For oral use only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result. For oral use in horses only. Do not use in horses intended for human consumption. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result Do not use in horses intended for human consumption.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

No case-level openFDA reports are linked for this medication yet.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.